P2RX7 and central nervous system cancer: To study the activity of P2X7 receptor in rat glioma C6 cells in vitro, we used BzATP (2' (3')-O-(4-benzoylbenzoyl) adenosine-5'-triphosphate) [36] and a highly potent antagonist Brilliant Blue G (BBG) [29, 37].